Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Statement re Share Consolidation

30 Sep 2014 15:11

RNS Number : 0490T
Maven Income & Growth VCT 4 PLC
30 September 2014
 

MAVEN INCOME AND GROWTH VCT 4 PLC

 

Completion of Share Consolidation

 

30 September 2014

 

This announcement is made by Maven Income and Growth VCT 4 plc ("the Company") in connection with the consolidation ("Share Consolidation") of the C ordinary shares of 10p each in the capital of the Company ("C Shares") into the ordinary shares of 10p each in the capital of the Company ("Ordinary Shares").

 

The Board of the Company is pleased to advise that the Share Consolidation has today been implemented, in accordance with the articles of association of the Company, as follows:

 

· 3,863,876 C Shares have been redesignated as 3,077,827 Ordinary Shares (based on a conversion ratio of 0.796847454551093 per holding of C Shares and rounded down to the nearest whole share); and

 

· the balance of the C Shares held by a C Shareholder which were not redesignated as Ordinary Shares were redesignated as deferred shares of 10p each, all of which have been bought back by the Company for an aggregate price of 1p and cancelled.

 

As a result of the above, the issued share capital of the Company now forms one class of share, Ordinary Shares, 32,499,188 of which are in issue. No Ordinary Shares are held in treasury by the Company.

 

Application has been made to the UKLA and the London Stock Exchange for amendments to the listing of the Ordinary Shares and C Shares to reflect the Share Consolidation.

 

Shareholders who hold their existing C Shares in certificated form will receive replacement certificates in respect of the Ordinary Shares arising from the Share Consolidation and existing share certificates in respect of C Shares will no longer be valid. Shareholders who hold their C Shares in CREST will have their CREST accounts updated.

 

For further enquiries please contact:

 

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZBLFXZKFFBBB
Date   Source Headline
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:18 pmRNSIssue of Equity
2nd Apr 20255:58 pmRNSAnnual Financial Report
1st Apr 20255:05 pmRNSDirectorate Change
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:12 pmRNSDirector/PDMR Shareholding
27th Mar 20251:07 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
18th Mar 20254:10 pmRNSTransaction in Own Shares
14th Mar 202511:58 amRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:20 amRNSDirector/PDMR Shareholding
19th Feb 202510:19 amRNSDirector/PDMR Shareholding
19th Feb 202510:18 amRNSDirector/PDMR Shareholding
19th Feb 202510:11 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202510:42 amRNSIssue of Equity
24th Jan 202511:34 amRNSNet Asset Value(s)
27th Dec 20249:21 amRNSDirector Declaration
10th Dec 20244:08 pmRNSTransaction in Own Shares
26th Nov 20244:20 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
18th Oct 20249:33 amRNSDirector/PDMR Shareholding
18th Oct 20249:29 amRNSIssue of Equity
15th Oct 20249:06 amRNSStatement re Dividend Investment Scheme
27th Sep 20244:31 pmRNSPublication of a Prospectus
18th Sep 202411:09 amRNSHalf-year Report
2nd Sep 20244:55 pmRNSTransaction in Own Shares
23rd Aug 20242:52 pmRNSStatement re NAV and Interim Dividend
24th May 202410:02 amRNSDirector/PDMR Shareholding
24th May 20249:58 amRNSIssue of Equity - Dividend Investment Scheme
15th May 20244:18 pmRNSTransaction in Own Shares
15th May 20242:17 pmRNSNet Asset Value - Dividend Investment Scheme
9th May 20242:35 pmRNSResult of AGM
9th May 20242:28 pmRNSUnaudited Net Asset Value
1st May 202410:08 amRNSIssue of Equity
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.